Patent valuation is a critical business issue, and the value of licensing deals has risen markedly in recent years 1. For example, Merck KGaA paid Idera Pharmaceuticals a $40 million licensing fee to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback